The ThinkEquity Conference
New York City
NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
NOW APPROVED
Journey Medical Corporation Announces the U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg for Treatment of Papulopustular Rosacea.
IR Calendar
We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.